HIGHLIGHTS
- who: Yongwei Gu from the Department of Pharmacy, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China have published the research work: αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma, in the Journal: (JOURNAL)
- what: Encouragingly, this study attempted to employ cRGD to engineer Exo, aiming to construct a melanoma-targeting Exo nanoplatform. Collectively, the research proposed a prototype melanoma-targeting delivery system for hydrophobic drugs, which provides a prospective strategy for the antitumor field.
- how: The in vitro antitumor results showed that the designed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.